Overview
Study information
Network: | CAVD |
Grant Affiliation: | Haynes: B cell Lineage Envelope Design from RV144 Antibodies |
Strategy: | Prophylactic neutralizing Ab |
Study Type: | Antibody Screening |
Species: | Non-Organism Study |
Stage: | Assays Completed |
Study Start Date: | 2016-09-12 |
Study Made Public: | 2017-09-29 |
Title
Investigating monoclonal antibody neutralization breadth and potency after delayed and repetitive boosting with ALVAC-HIV and AIDSVAX B/E
Description
CAVD 611 is a monoclonal antibody screening study evaluating neutralization activity from RV144/RV305 participant samples.
Sign in to see full information about this study and to download study data.
Products
ALVAC (vCP1521) AIDSVAX B/E Saline (non-specific) Placebo ALVAC Placebo AIDSVAX B/EIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.